However, high c-Met overexpression was not found to be associated with Menopausal status, OR=0.758 (0.529, 1.086); age, OR=1.072 (0.699, 1.645); ER status, OR=1.049 (0.679, 1.619); PR status, OR=1.300 (0.782, 2.161); HER-2 status, OR =1.017 (0.683, 1.516); triple negative breast cancer, OR=0.956 (0.443, 2.063); ki-67 overexpression, OR=1.677 (0.837, 3.362); lymph node status, OR=1.801 (0.991, 3.274); histologic type, OR=1.053 (0.566, 1.960). This evidence concerns the gene MET and triple-negative breast carcinoma.